54 related articles for article (PubMed ID: 8958518)
1. Development of a target-directed magnetic resonance contrast agent using monoclonal antibody-conjugated magnetic particles.
Suzuki M; Honda H; Kobayashi T; Wakabayashi T; Yoshida J; Takahashi M
Noshuyo Byori; 1996 Nov; 13(2):127-32. PubMed ID: 8958518
[TBL] [Abstract][Full Text] [Related]
2. What's new in imaging? New magnetic resonance imaging of esophageal cancer using an endoluminal surface coil and antibody-coated magnetite particles.
Ozawa S; Imai Y; Suwa T; Kitajima M
Recent Results Cancer Res; 2000; 155():73-87. PubMed ID: 10693240
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody-coated magnetite particles as contrast agents in magnetic resonance imaging of tumors.
Cerdan S; Lötscher HR; Künnecke B; Seelig J
Magn Reson Med; 1989 Nov; 12(2):151-63. PubMed ID: 2615625
[TBL] [Abstract][Full Text] [Related]
4. Use of magnetite particles as a contrast agent for MR imaging of the liver.
Kawamura Y; Endo K; Watanabe Y; Saga T; Nakai T; Hikita H; Kagawa K; Konishi J
Radiology; 1990 Feb; 174(2):357-60. PubMed ID: 2296645
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody-coated magnetite particles as contrast agents for MR imaging and laser therapy of human tumors.
To SY; Castro DJ; Lufkin RB; Soudant J; Saxton RE
J Clin Laser Med Surg; 1992 Jun; 10(3):159-69. PubMed ID: 10147859
[TBL] [Abstract][Full Text] [Related]
6. [Magnet resonance spectroscopy of tumor-bearing rat livers: magnetite particles as an aid in volume selection].
Römer T; Gewiese B; Stiller D; Plötz M; Lawaczeck R; Wolf KJ
Rofo; 1990 Jul; 153(1):79-84. PubMed ID: 2166318
[TBL] [Abstract][Full Text] [Related]
7. Magnetite albumin microspheres: a new MR contrast material.
Widder DJ; Greif WL; Widder KJ; Edelman RR; Brady TJ
AJR Am J Roentgenol; 1987 Feb; 148(2):399-404. PubMed ID: 3492120
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging of esophageal squamous cell carcinoma using magnetite particles coated with anti-epidermal growth factor receptor antibody.
Suwa T; Ozawa S; Ueda M; Ando N; Kitajima M
Int J Cancer; 1998 Feb; 75(4):626-34. PubMed ID: 9466667
[TBL] [Abstract][Full Text] [Related]
9. Enhanced magnetic resonance imaging of experimental pancreatic tumor in vivo by block copolymer-coated magnetite nanoparticles with TGF-beta inhibitor.
Kumagai M; Kano MR; Morishita Y; Ota M; Imai Y; Nishiyama N; Sekino M; Ueno S; Miyazono K; Kataoka K
J Control Release; 2009 Dec; 140(3):306-11. PubMed ID: 19524625
[TBL] [Abstract][Full Text] [Related]
10. Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles.
Bulte JW; Hoekstra Y; Kamman RL; Magin RL; Webb AG; Briggs RW; Go KG; Hulstaert CE; Miltenyi S; The TH
Magn Reson Med; 1992 May; 25(1):148-57. PubMed ID: 1375703
[TBL] [Abstract][Full Text] [Related]
11. Our approach towards developing a specific tumour-targeted MRI contrast agent for the brain.
Go KG; Bulte JW; de Ley L; The TH; Kamman RL; Hulstaert CE; Blaauw EH; Ma LD
Eur J Radiol; 1993 Apr; 16(3):171-5. PubMed ID: 7685284
[TBL] [Abstract][Full Text] [Related]
12. Direct visualization of peritumoral rims.
Kruskal JB
AJR Am J Roentgenol; 1997 Aug; 169(2):595-6. PubMed ID: 9242784
[No Abstract] [Full Text] [Related]
13. In vivo evaluation of magnetite nanoparticles for use as a tumor contrast agent in MRI.
Tiefenauer LX; Tschirky A; Kühne G; Andres RY
Magn Reson Imaging; 1996; 14(4):391-402. PubMed ID: 8782177
[TBL] [Abstract][Full Text] [Related]
14. Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging.
Tiefenauer LX; Kühne G; Andres RY
Bioconjug Chem; 1993; 4(5):347-52. PubMed ID: 8274518
[TBL] [Abstract][Full Text] [Related]
15. MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis.
Remsen LG; McCormick CI; Roman-Goldstein S; Nilaver G; Weissleder R; Bogdanov A; Hellström I; Kroll RA; Neuwelt EA
AJNR Am J Neuroradiol; 1996 Mar; 17(3):411-8. PubMed ID: 8881233
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characteristics of magnetite-labelled antibody with the use of poly(ethylene glycol) derivatives.
Suzuki M; Shinkai M; Kamihira M; Kobayashi T
Biotechnol Appl Biochem; 1995 Jun; 21(3):335-45. PubMed ID: 7794535
[TBL] [Abstract][Full Text] [Related]
17. Quantification of the expression level of integrin receptor alpha(v)beta3 in cell lines and MR imaging with antibody-coated iron oxide particles.
Benedetto S; Pulito R; Crich SG; Tarone G; Aime S; Silengo L; Hamm J
Magn Reson Med; 2006 Oct; 56(4):711-6. PubMed ID: 16958071
[TBL] [Abstract][Full Text] [Related]
18. Determinants of in vivo MR imaging of slow axonal transport.
van Everdingen KJ; Enochs WS; Bhide PG; Nossiff N; Papisov M; Bogdanov A; Brady TJ; Weissleder R
Radiology; 1994 Nov; 193(2):485-91. PubMed ID: 7526413
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of magnetite nanoparticle clusters in fluorescent silica nanoparticles for high-performance brain tumor delineation.
Wan J; Meng X; Liu E; Chen K
Nanotechnology; 2010 Jun; 21(23):235104. PubMed ID: 20472942
[TBL] [Abstract][Full Text] [Related]
20. Antibody-conjugated magnetoliposomes for targeting cancer cells and their application in hyperthermia.
Shinkai M; Suzuki M; Iijima S; Kobayashi T
Biotechnol Appl Biochem; 1995 Apr; 21(2):125-37. PubMed ID: 7718156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
